{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:04:57Z","timestamp":1783004697170,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s12928-024-01062-w","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T05:02:49Z","timestamp":1729659769000},"page":"112-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of body mass index on mortality, limb amputation, and bleeding in patients with lower extremity artery disease undergoing endovascular therapy"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2317-7725","authenticated-orcid":false,"given":"Takuya","family":"Nakahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Takeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"1062_CR1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.5551\/jat.53330","volume":"27","author":"M Takahara","year":"2020","unstructured":"Takahara M, Iida O, Kohsaka S, Soga Y, Fujihara M, Shinke T, et al. Presentation pattern of lower extremity endovascular intervention versus percutaneous coronary intervention. J Atheroscler Thromb. 2020;27:761\u20138.","journal-title":"J Atheroscler Thromb"},{"key":"1062_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1001\/jamacardio.2018.4171","volume":"4","author":"CB Olivier","year":"2019","unstructured":"Olivier CB, Mulder H, Hiatt WR, Jones WS, Fowkes FGR, Rockhold FW, et al. Incidence, characteristics, and outcomes of myocardial infarction in patients with peripheral artery disease: insights from the EUCLID trial. JAMA Cardiol. 2019;4:7\u201315.","journal-title":"JAMA Cardiol"},{"key":"1062_CR3","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","volume":"35","author":"DJ Kumbhani","year":"2014","unstructured":"Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Goto S, et al. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J. 2014;35:2864\u201372.","journal-title":"Eur Heart J"},{"key":"1062_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/15266028221134886","author":"O Kawarada","year":"2022","unstructured":"Kawarada O, Zen K, Hozawa K, Obara H, Matsubara K, Yamamoto Y, et al. Characteristics, antithrombotic patterns, and prognostic outcomes in claudication and critical limb-threatening ischemia undergoing endovascular therapy. J Endovasc Ther. 2022. https:\/\/doi.org\/10.1177\/15266028221134886.","journal-title":"J Endovasc Ther"},{"key":"1062_CR5","first-page":"e686","volume":"135","author":"MD Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e686\u2013725.","journal-title":"Circulation"},{"key":"1062_CR6","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.jcin.2019.03.012","volume":"12","author":"B Bhardwaj","year":"2019","unstructured":"Bhardwaj B, Spertus JA, Kennedy KF, Jones WS, Safley D, Tsai TT, et al. Bleeding complications in lower-extremity peripheral vascular interventions: insights from the NCDR PVI registry. JACC Cardiovasc Interv. 2019;12:1140\u20139.","journal-title":"JACC Cardiovasc Interv"},{"key":"1062_CR7","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1007\/s00380-021-01813-2","volume":"36","author":"R Hashimoto","year":"2021","unstructured":"Hashimoto R, Numasawa Y, Yokokura S, Daigo K, Sakata S, Imaeda S, et al. Prevalence of the Academic Research Consortium high bleeding risk criteria in patients undergoing endovascular therapy for peripheral artery disease in lower extremities. Heart Vessels. 2021;36:1350\u20138.","journal-title":"Heart Vessels"},{"key":"1062_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.118.006778","author":"Y Takeji","year":"2018","unstructured":"Takeji Y, Yamaji K, Tomoi Y, Okazaki J, Tanaka K, Nagae A, et al. Impact of frailty on clinical outcomes in patients with critical limb ischemia. Circ Cardiovasc Interv. 2018. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.118.006778.","journal-title":"Circ Cardiovasc Interv"},{"key":"1062_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0002-9149(96)00386-4","volume":"78","author":"SG Ellis","year":"1996","unstructured":"Ellis SG, Elliott J, Horrigan M, Raymond RE, Howell G. Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. Am J Cardiol. 1996;78:642\u20136.","journal-title":"Am J Cardiol"},{"key":"1062_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ejvs.2014.10.014","volume":"49","author":"N Murata","year":"2015","unstructured":"Murata N, Soga Y, Iida O, Yamauchi Y, Hirano K, Kawasaki D, et al. Complex relationship of body mass index with mortality in patients with critical limb ischemia undergoing endovascular treatment. Eur J Vasc Endovasc Surg. 2015;49:297\u2013305.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"1062_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ahj.2019.11.007","volume":"220","author":"R Ward","year":"2020","unstructured":"Ward R, Huang Z, Rockhold FW, Baumgartner I, Berger JS, Blomster JI, et al. Major bleeding in patients with peripheral artery disease: insights from the EUCLID trial. Am Heart J. 2020;220:51\u20138.","journal-title":"Am Heart J"},{"key":"1062_CR12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.5551\/jat.47654","volume":"26","author":"R Yoshida","year":"2019","unstructured":"Yoshida R, Ishii H, Morishima I, Tanaka A, Morita Y, Takagi K, et al. Impact of nutritional and inflammation status on long-term bleeding in patients undergoing percutaneous coronary intervention with an oral anticoagulant. J Atheroscler Thromb. 2019;26:728\u201337.","journal-title":"J Atheroscler Thromb"},{"key":"1062_CR13","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00380-023-02276-3","volume":"38","author":"H Shimono","year":"2023","unstructured":"Shimono H, Tokushige A, Kanda D, Ohno A, Hayashi M, Fukuyado M, et al. Association of preoperative clinical frailty and clinical outcomes in elderly patients with stable coronary artery disease after percutaneous coronary intervention. Heart Vessels. 2023;38:1205\u201317.","journal-title":"Heart Vessels"},{"key":"1062_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s12928-022-00875-x","volume":"37","author":"M Fujihara","year":"2022","unstructured":"Fujihara M, Kurata N, Yazu Y, Mori S, Tomoi Y, Horie K, et al. Clinical expert consensus document on standards for lower extremity artery disease of imaging modality from the Japan Endovascular Treatment Conference. Cardiovasc Interv Ther. 2022;37:597\u2013612.","journal-title":"Cardiovasc Interv Ther"},{"issue":"Suppl S","key":"1062_CR15","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5-67.","journal-title":"J Vasc Surg"},{"key":"1062_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/1526602815592206","volume":"22","author":"MR Jaff","year":"2015","unstructured":"TASC Steering Committee, Jaff MR, White CJ, Hiatt WR, Fowkes GR, Dormandy J, Razavi M, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Endovasc Ther. 2015;22:663\u201377.","journal-title":"J Endovasc Ther"},{"key":"1062_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","volume":"140","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention. Circulation. 2019;140:240\u201361.","journal-title":"Circulation"},{"key":"1062_CR18","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1253\/circj.CJ-20-0395","volume":"84","author":"K Miura","year":"2020","unstructured":"Miura K, Shimada T, Ohya M, Murai R, Amano H, Kubo S, et al. Prevalence of the academic research consortium for high bleeding risk criteria and prognostic value of a simplified definition. Circ J. 2020;84:1560\u20137.","journal-title":"Circ J"},{"key":"1062_CR19","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736\u201347.","journal-title":"Circulation"},{"key":"1062_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/CIRCINTERVENTIONS.113.000433","volume":"6","author":"G Ndrepepa","year":"2013","unstructured":"Ndrepepa G, Neumann FJ, Richardt G, Schulz S, T\u00f6lg R, Stoyanov KM, et al. Prognostic value of access and non-access sites bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv. 2013;6:354\u201361.","journal-title":"Circ Cardiovasc Interv"},{"key":"1062_CR21","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.jfma.2019.10.011","volume":"119","author":"HL Huang","year":"2020","unstructured":"Huang HL, Tzeng IS, Chou HH, Hsieh CA, Jang SJ, Ko YL, et al. Contemporary cardiovascular outcomes in Taiwanese patients undergoing endovascular therapy for symptomatic lower extremity peripheral arterial disease. J Formos Med Assoc. 2020;119:1052\u201360.","journal-title":"J Formos Med Assoc"},{"key":"1062_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.avsg.2023.02.010","volume":"94","author":"K Morisaki","year":"2023","unstructured":"Morisaki K, Guntani A, Matsuda D, Matsubara Y, Kinoshita G, Kawanami S, et al. Risk factors for major amputation in chronic limb-threatening ischemia patients classified as wound, ischemia, and foot infection stage 4 following infrainguinal revascularization. Ann Vasc Surg. 2023;94:246\u201352.","journal-title":"Ann Vasc Surg"},{"key":"1062_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jjcc.2019.01.008","volume":"74","author":"T Nakahashi","year":"2019","unstructured":"Nakahashi T, Tada H, Sakata K, Yakuta Y, Tanaka Y, Gamou T, et al. Impact of decreased ankle-brachial index on 30-day bleeding complications and long-term mortality in patients with acute coronary syndrome after percutaneous coronary intervention. J Cardiol. 2019;74:116\u201322.","journal-title":"J Cardiol"},{"key":"1062_CR24","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jvs.2014.12.051","volume":"61","author":"K Sato","year":"2015","unstructured":"Sato K, Iida O, Takahara M, Soga Y, Suzuki K, Tanigawa T, et al. Effect of perioperative complications after endovascular therapy in patients with peripheral artery disease due to femoropopliteal lesions. J Vasc Surg. 2015;61:1272\u20137.","journal-title":"J Vasc Surg"},{"key":"1062_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010070","author":"M Kim","year":"2018","unstructured":"Kim M, Kim MA, Kim HL, Lee WJ, Lim WH, Seo JB, et al. Body mass index and the risk of low femoral artery puncture in coronary angiography under fluoroscopy guidance. Medicine (Baltimore). 2018. https:\/\/doi.org\/10.1097\/MD.0000000000010070.","journal-title":"Medicine (Baltimore)"},{"key":"1062_CR26","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jacc.2015.06.1323","volume":"66","author":"P G\u00e9n\u00e9reux","year":"2015","unstructured":"G\u00e9n\u00e9reux P, Giustino G, Witzenbichler B, Weisz G, Stuckey TD, Rinaldi MJ, et al. Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention. J Am Coll Cardiol. 2015;66:1036\u201345.","journal-title":"J Am Coll Cardiol"},{"key":"1062_CR27","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.amjcard.2014.11.022","volume":"115","author":"G Ndrepepa","year":"2015","unstructured":"Ndrepepa G, Fusaro M, Cassese S, Guerra E, Schunkert H, Kastrati A. Relation of body mass index to bleeding during percutaneous coronary interventions. Am J Cardiol. 2015;115:434\u201340.","journal-title":"Am J Cardiol"},{"key":"1062_CR28","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jvs.2010.05.020","volume":"52","author":"H Ishii","year":"2010","unstructured":"Ishii H, Kumada Y, Toriyama T, Aoyama T, Takahashi H, Murohara T. Prognostic values of C-reactive protein levels on clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease. J Vasc Surg. 2010;52:854\u20139.","journal-title":"J Vasc Surg"},{"key":"1062_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/2050312115597087","author":"T Tsuchiya","year":"2015","unstructured":"Tsuchiya T, Iida O, Shiraki T, Soga Y, Hirano K, Suzuki K, et al. Clinical characteristics of patients with Rutherford category IV, compared with V and VI. SAGE Open Med. 2015. https:\/\/doi.org\/10.1177\/2050312115597087.","journal-title":"SAGE Open Med"},{"key":"1062_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","volume":"51","author":"WB Ershler","year":"2000","unstructured":"Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000;51:245\u201370.","journal-title":"Annu Rev Med"},{"key":"1062_CR31","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1253\/circj.CJ-17-0015","volume":"81","author":"Y Tatami","year":"2017","unstructured":"Tatami Y, Ishii H, Aoki T, Harada K, Hirayama K, Shibata Y, et al. Decreased serum albumin predicts bleeding events in patients on antiplatelet therapy after percutaneous coronary intervention. Circ J. 2017;81:999\u20131005.","journal-title":"Circ J"},{"key":"1062_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/jcsm.12039","volume":"7","author":"AJ Montano-Loza","year":"2016","unstructured":"Montano-Loza AJ, Angulo P, Meza-Junco J, Prado CM, Sawyer MB, Beaumont C, et al. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J Cachexia Sarcopenia Muscle. 2016;7:126\u201335.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1062_CR33","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.111.064378","volume":"125","author":"L Venkitachalam","year":"2012","unstructured":"Venkitachalam L, Wang K, Porath A, Corbalan R, Hirsch AT, Cohen DJ, et al. Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance. Circulation. 2012;125:1858\u201369.","journal-title":"Circulation"},{"key":"1062_CR34","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","volume":"382","author":"MP Bonaca","year":"2020","unstructured":"Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, et al. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med. 2020;382:1994\u20132004.","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-024-01062-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-024-01062-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-024-01062-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T18:12:59Z","timestamp":1736532779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-024-01062-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1062"],"URL":"https:\/\/doi.org\/10.1007\/s12928-024-01062-w","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"3 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}